Schoenherr (Schönherr Rechtsanwälte)

Schoenherr (Schönherr Rechtsanwälte)

Client Satisfaction

News and developments

Schoenherr recognised as leading Austrian M&A Legal Advisor for 2021 by Mergermarket

Schoenherr has, yet again, been named top M&A legal advisor in the Austrian market by Mergermarket. For over a decade, Schoenherr has been leading the Austrian Mergermarket M&A league tables.


Every year, the leading M&A business intelligence provider Mergermarket compiles and analyses comprehensive deal data. According to their results published on 19 January, Schoenherr advised on the highest number of qualifying M&A transactions, with the highest deal value in Austria in 2021.

By advising on 29 Austria-related deals, with a combined deal value of EUR 11.17bln, Schoenherr has outperformed other advisors considered for the ranking. In addition, Schoenherr has maintained its excellent ranking in the CEE jurisdiction: Schoenherr is one of only two Austria-based law firms in the top 10 in CEE by number of deals.

2021 marks the third consecutive year in which Schoenherr has won the Mergermarket ranking for Austria in both objectively evaluated categories being value and number of qualifying transactions. Schoenherr has led the Austrian Mergermarket ranking in at least one of the two ranking categories for more than a decade. 

"This impressive success streak underlines Schoenherr's outstanding force in the market both in high-end and mid-market private and public M&A transactions", said co-heads of Schoenherr's renowned M&A practice, Sascha Hödl and Roman Perner. "We can only reemphasise how proud we are of this incredible teamwork from across all of our offices. Our combined know-how and constant drive to go further for our clients pays off and distinguishes us as leading experts in the legal field."

2021 headline M&A transactions which contributed towards the rankings include:

  • Starwood Capital Group on the successful public offer for CA Immo;
  • Cerba HealthCare on the acquisition of Lifebrain Group from Investindustrial;
  • Sanofi on the acquisition of Origimm Biotechnology;
  • OMV AG on the sale of 92.25 % of the shares in OMV Slovenija to MOL Group (Hungary);
  • UBS' sale of its Austrian wealth management business to LGT; and
  • Adevinta selling Shpock to Russmedia.